These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 25837854

  • 21. Early Medical Treatment of Children and Adolescents With Gender Dysphoria: An Empirical Ethical Study.
    Vrouenraets LJ, Fredriks AM, Hannema SE, Cohen-Kettenis PT, de Vries MC.
    J Adolesc Health; 2015 Oct; 57(4):367-73. PubMed ID: 26119518
    [Abstract] [Full Text] [Related]

  • 22. Gender Dysphoria and Anorexia Nervosa Symptoms in Two Adolescents.
    Ristori J, Fisher AD, Castellini G, Sensi C, Cipriani A, Ricca V, Maggi M.
    Arch Sex Behav; 2019 Jul; 48(5):1625-1631. PubMed ID: 30815831
    [Abstract] [Full Text] [Related]

  • 23. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
    Ramos GGF, Mengai ACS, Daltro CAT, Cutrim PT, Zlotnik E, Beck APA.
    J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
    [Abstract] [Full Text] [Related]

  • 24. Blood Pressure Dynamics After Pubertal Suppression with Gonadotropin-Releasing Hormone Analogs Followed by Testosterone Treatment in Transgender Male Adolescents: A Pilot Study.
    Perl L, Segev-Becker A, Israeli G, Elkon-Tamir E, Oren A.
    LGBT Health; 2020 Jun; 7(6):340-344. PubMed ID: 32735503
    [Abstract] [Full Text] [Related]

  • 25. Brain Maturation, Cognition and Voice Pattern in a Gender Dysphoria Case under Pubertal Suppression.
    Schneider MA, Spritzer PM, Soll BMB, Fontanari AMV, Carneiro M, Tovar-Moll F, Costa AB, da Silva DC, Schwarz K, Anes M, Tramontina S, Lobato MIR.
    Front Hum Neurosci; 2017 Jun; 11():528. PubMed ID: 29184488
    [Abstract] [Full Text] [Related]

  • 26. Peri-pubertal gonadotropin-releasing hormone agonist treatment affects sex biased gene expression of amygdala in sheep.
    Nuruddin S, Krogenæs A, Brynildsrud OB, Verhaegen S, Evans NP, Robinson JE, Haraldsen IR, Ropstad E.
    Psychoneuroendocrinology; 2013 Dec; 38(12):3115-27. PubMed ID: 24103890
    [Abstract] [Full Text] [Related]

  • 27. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort.
    Joseph T, Ting J, Butler G.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1077-1081. PubMed ID: 31472062
    [Abstract] [Full Text] [Related]

  • 28. Effects of peripubertal gonadotropin-releasing hormone agonist on brain development in sheep--a magnetic resonance imaging study.
    Sex On Brain European Research Group – SOBERNorwegian School of Veterinary Science, PB 8146 Dep, 0033 Oslo, Norway., Nuruddin S, Bruchhage M, Ropstad E, Krogenæs A, Evans NP, Robinson JE, Endestad T, Westlye LT, Madison C, Haraldsen IR.
    Psychoneuroendocrinology; 2013 Oct 25; 38(10):1994-2002. PubMed ID: 23579083
    [Abstract] [Full Text] [Related]

  • 29. Inter-Network Brain Functional Connectivity in Adolescents Assigned Female at Birth Who Experience Gender Dysphoria.
    Skorska MN, Lobaugh NJ, Lombardo MV, van Bruggen N, Chavez S, Thurston LT, Aitken M, Zucker KJ, Chakravarty MM, Lai MC, VanderLaan DP.
    Front Endocrinol (Lausanne); 2022 Oct 25; 13():903058. PubMed ID: 35937791
    [Abstract] [Full Text] [Related]

  • 30. To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.
    Costa R, Carmichael P, Colizzi M.
    Nat Rev Urol; 2016 Aug 25; 13(8):456-62. PubMed ID: 27431339
    [Abstract] [Full Text] [Related]

  • 31. Young adult psychological outcome after puberty suppression and gender reassignment.
    de Vries AL, McGuire JK, Steensma TD, Wagenaar EC, Doreleijers TA, Cohen-Kettenis PT.
    Pediatrics; 2014 Oct 25; 134(4):696-704. PubMed ID: 25201798
    [Abstract] [Full Text] [Related]

  • 32. Puberty suppression in gender identity disorder: the Amsterdam experience.
    Kreukels BP, Cohen-Kettenis PT.
    Nat Rev Endocrinol; 2011 May 17; 7(8):466-72. PubMed ID: 21587245
    [Abstract] [Full Text] [Related]

  • 33. Management of juvenile gender dysphoria.
    Hembree WC.
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec 17; 20(6):559-64. PubMed ID: 24468758
    [Abstract] [Full Text] [Related]

  • 34. Sudden sex hormone withdrawal and the effects on body composition in late pubertal adolescents with gender dysphoria.
    Ghelani R, Lim C, Brain C, Fewtrell M, Butler G.
    J Pediatr Endocrinol Metab; 2020 Jan 28; 33(1):107-112. PubMed ID: 31834861
    [Abstract] [Full Text] [Related]

  • 35. Back to the Future: Is GnRHa Treatment in Transgender and Gender Diverse Adolescents Only an Extended Evaluation Phase?
    Fisher AD, Ristori J, Romani A, Cassioli E, Mazzoli F, Cocchetti C, Pierdominici M, Marconi M, Ricca V, Maggi M, Vignozzi L, Castellini G.
    J Clin Endocrinol Metab; 2024 May 17; 109(6):1565-1579. PubMed ID: 38099569
    [Abstract] [Full Text] [Related]

  • 36. [Beyond NICE: Updated Systematic Review on the Current Evidence of Using Puberty Blocking Pharmacological Agents and Cross-Sex-Hormones in Minors with Gender Dysphoria].
    Zepf FD, König L, Kaiser A, Ligges C, Ligges M, Roessner V, Banaschewski T, Holtmann M.
    Z Kinder Jugendpsychiatr Psychother; 2024 May 17; 52(3):167-187. PubMed ID: 38410090
    [Abstract] [Full Text] [Related]

  • 37. Biopsychosocial Assessments for Pubertal Suppression to Treat Adolescent Gender Dysphoria.
    Turban JL, Thornton J, Ehrensaft D.
    J Am Acad Child Adolesc Psychiatry; 2024 Apr 04. PubMed ID: 38582366
    [Abstract] [Full Text] [Related]

  • 38. Gender dysphoria in children and adolescents: an overview.
    Skordis N, Kyriakou A, Dror S, Mushailov A, Nicolaides NC.
    Hormones (Athens); 2020 Sep 04; 19(3):267-276. PubMed ID: 32020566
    [Abstract] [Full Text] [Related]

  • 39. CHILDREN AND ADOLESCENTS WITH GENDER DYSPHORIA IN ISRAEL: INCREASING REFERRAL AND FERTILITY PRESERVATION RATES.
    Segev-Becker A, Israeli G, Elkon-Tamir E, Perl L, Sekler O, Amir H, Interator H, Dayan SC, Chorna E, Weintrob N, Oren A.
    Endocr Pract; 2020 Apr 04; 26(4):423-428. PubMed ID: 32045294
    [Abstract] [Full Text] [Related]

  • 40. Hypothalamic response to the chemo-signal androstadienone in gender dysphoric children and adolescents.
    Burke SM, Cohen-Kettenis PT, Veltman DJ, Klink DT, Bakker J.
    Front Endocrinol (Lausanne); 2014 Apr 04; 5():60. PubMed ID: 24904525
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.